<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Rovers, M.J.</title>
    <link>http://repub.eur.nl/res/aut/8146/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Functional hyperactivity of hepatic glutamate dehydrogenase as a cause of the hyperinsulinism/hyperammonemia syndrome: effect of treatment (Article)</title>
      <link>http://repub.eur.nl/res/pub/9445/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: The combination of persistent hyperammonemia and hypoketotic
          hypoglycemia in infancy presents a diagnostic challenge. Investigation of
          the possible causes and regulators of the ammonia and glucose disposal may
          result in a true diagnosis and predict an optimum treatment. PATIENT:
          Since the neonatal period, a white girl had been treated for
          hyperammonemia and postprandial hypoglycemia with intermittent
          hyperinsulinism. Her blood level of ammonia varied from 100 to 300
          micromol/L and was independent of the protein intake. METHODS: Enzymes of
          the urea cycle as well as glutamine synthetase and glutamate dehydrogenase
          (GDH) were assayed in liver tissue and/or lymphocytes. RESULTS: The
          activity of hepatic GDH was 874 nmol/(min.mg protein) (controls: 472-938).
          Half-maximum inhibition by guanosine triphosphate was reached at a
          concentration of 3.9 micromol/L (mean control values:.32). The ratio of
          plasma glutamine/blood ammonia was unusually low. Oral supplements with
          N-carbamylglutamate resulted in a moderate decrease of the blood level of
          ammonia. The hyperinsulinism was successfully treated with diazoxide.
          CONCLUSION: A continuous conversion of glutamate to 2-oxoglutarate causes
          a depletion of glutamate needed for the synthesis of N-acetylglutamate,
          the catalyst of the urea synthesis starting with ammonia. In addition, the
          shortage of glutamate may lead to an insufficient formation of glutamine
          by glutamine synthetase. As GDH stimulates the release of insulin, the
          concomitant hyperinsulinism can be explained. This disorder should be
          considered in every patient with postprandial hypoglycemia and
          diet-independent hyperammonemia.</description>
    </item>
  </channel>
</rss>